- Home
- PLRX vs NCTY Comparison
PLRX vs NCTY Comparison
Compare PLRX & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | NCTY |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9M | 84.0M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PLRX | NCTY |
|---|---|---|
| Price | $1.15 | $5.77 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 477.1K | 32.8K |
| Earning Date | 05-06-2026 | 03-27-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $5.00 |
| 52 Week High | $1.95 | $12.48 |
Technical Indicators
Market Signals| Indicator | PLRX | NCTY |
|---|---|---|
| Relative Strength Index (RSI) | 32.48 | 50.49 |
| Support Level | $1.10 | $5.03 |
| Resistance Level | $1.37 | $5.91 |
| Average True Range (ATR) | 0.04 | 0.42 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 7.14 | 39.41 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Online game services, out of which Crypto mining business derives maximum revenue.